{"database": "lobbying", "table": "lobbying_activities", "rows": [[623301, "31d342a3-8abc-4df0-b964-c44332f2fa35", "Q2", "CAPITOL HILL CONSULTING GROUP", 72053, "ASTELLAS PHARMA US", 2008, "second_quarter", "PHA", "Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug importation; and drug safety", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2008-07-09T10:37:18-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["623301"], "units": {}, "query_ms": 0.2818549983203411, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}